# A Study in Healthy Volunteers

> **NCT03596697** · PHASE1 · COMPLETED · sponsor: **Hepion Pharmaceuticals, Inc.** · enrollment: 92 (actual)

## Conditions studied

- Hepatitis B
- Infectious Disease
- Liver Diseases

## Interventions

- **DRUG:** CRV431
- **DRUG:** Placebo
- **DRUG:** TDF

## Key facts

- **NCT ID:** NCT03596697
- **Lead sponsor:** Hepion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-09
- **Primary completion:** 2020-09-30
- **Final completion:** 2021-06-04
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2021-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03596697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03596697, "A Study in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03596697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*